All abstracts
Home
Scientific Programme
Industry Sessions
Live Sessions
Abstracts
E-posters
Sponsors and Exhibitors
All
Posters
Topics
Presentation Type
Loading
Clear all filters
EPP021
Postpartum depression in outpatient care in Latvia: symptom prevalence and associated clinical and sociodemographic factors
EPP022
Social Isolation and Incident Post-Stroke Depression: A Population-Based Cohort Study
EPP023
Long-Term Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: A Real-World, Single-arm Study of Over 100 sessions
EPP024
Association Between Childhood Neglect and Major Depressive Disorder: A Systematic Review, Meta-Analysis and Meta-Regression
EPP025
Associations Between Stress-Coping Strategies and Treatment Discontinuation in Mood Disorders
EPP026
Dissociation Does Not Mediate Antidepressant Response to Esketamine: A Real-World Longitudinal Study with 6-Month Follow-Up
EPP027
Voice Analysis of Free-Speech for the Detection of Depression among Arabic-Speaking Refugee Women: A Pilot Machine Learning Study
EPP028
Major depression and glucidic metabolism: a prospective assessment of response to treatment with antidepressant drugs
EPP029
Long-term maintenance therapy with ketamine infusions for treatment-resistant depression: a retrospective chart review
EPP030
Predictors of postpartum depressive symptoms: time perspective and circadian rhythm disturbances in early pregnancy.
EPP031
Prevalence of Folate Deficiency Amongst Patients in a Secondary Care Outpatient Mental Health Service
EPP032
Reduction of Suicidality and Depressive Symptoms with Esketamine: Focus on Gender Differences
EPP033
A retrospective clinical audit on depression management in line with NICE NG222 guidelines at a primary care setting in rural England
EPP034
Agreement and Divergence Between Clinician-Rated and Self-Report Measures of Depression Symptom Severity
EPP035
Plasmatic GABA levels and its relation with GRIN2B haplotypes and treatment resistant depression patients.
EPP036
Role of ACEI/ARBs on antidepressant treatment response assessed through biomarker levels and gene expression analysis in persons with depression: A prospective observational study
EPP037
Norepinephrine Transporter (SLC6A2) Polymorphisms and their Impact on SSRI/SNRI Treatment response in Indian Patients with Depressive Disorder: A preliminary study
EPP038
Association of abnormal high-density lipoprotein cholesterol with depressive symptoms and variations by gender: Preliminary results from Singapore’s PREDICT study
EPP039
Long term efficacy and safety of GH001 in patients with treatment-resistant depression
EPP040
What routine mental healthcare data could be used to predict response in major depression treatment?
1864
abstracts
1
2
3
...
94